![]() |
The new test is part of a research program aimed at predicting the risk of developing four types of cancer from a single cell sample from the cervix. Credit: Mart Production |
Researchers at Karolinska Institutet, among others, have developed a screening test for cervical cancer that can predict cell changes several years before they are visible under the microscope. The test is also better at identifying high-grade cell changes in gynecological cell samples than today's methods. It shows a study published in the journal Genome Medicine.
The method has the potential to improve today's screening program and enable a previous intervention to prevent cancer, says Karin Sundström, doctor at Karolinska University Hospital and senior researcher at Department of Laboratory Medicine, Karolinska Institutet.
The test was developed by an international research team from Karolinska Institutet, Innsbruck University in Austria and University College London (UCL) in the United Kingdom. It is part of a research program aimed at predicting the risk of developing four types of cancer (breast, ovarian, uterine and cervical cancer) from a single cell sample from the cervix. Previous studies have shown that the test may detect the risk of breast and ovarian cancer by analyzing a regular cell sample from the cervix.